Research Peptides

Tesamorelin

Name: Tesamorelin
Brand: Riptide Peptides
Availability: InStock

≥99% purityLyophilized powderThird-party COA

Tesamorelin is supplied as a sterile lyophilized powder in a sealed glass vial, manufactured to ≥99% purity. Every batch is verified by independent third-party analysis and ships with a Certificate of Analysis.

$49.99

Size

✓ Same-day dispatch
✓ Discreet packaging
✓ Third-party tested batch
✓ COA available

View Certificate of Analysis →

Certificate of analysis

⚠ Research use only. This product is intended solely for in-vitro laboratory research by qualified professionals. Not for human or veterinary use.

Research overview

About Tesamorelin

Tesamorelin is a synthetic 44-amino acid peptide analog of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoyl modification at the N-terminus for increased stability and potency.

It stimulates the pituitary gland to release endogenous growth hormone (GH) in a pulsatile manner. In research models, Tesamorelin is studied for its ability to reduce visceral adipose tissue (abdominal fat), improve body composition, and support metabolic health while maintaining a more physiological GH release profile compared to direct GH administration.

Key Research Areas

Growth hormone stimulation and pulsatile release
Visceral fat reduction and body composition
Metabolic regulation and lipid metabolism
Anti-aging and longevity models
HIV-associated lipodystrophy and endocrine studies

Sources & references6 peer-reviewed publications and databases

Effects of tesamorlin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials
Falutz J, et al.
2010 · PMID: 20554713
Effects of tesamorlin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial
Stanley TL, et al.
2019 · PMID: 31611038
Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults
Baker LD, et al.
2012 · PMID: 22869065
The Growth Hormone Releasing Hormone Analogue, Tesamorlin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV
Adrian S, et al.
2019 · PMID: 31050749
Effects of tesamorlin on hepatic transcriptomic signatures in HIV-associated NAFLD
Fourman LT, et al.
2020 · PMID: 32780726
EGRIFTA (tesamorlin) Prescribing Information
2025

Research summaries and references are drawn from published, peer-reviewed literature and are provided for educational reference only. They are not product claims or medical advice. This product is sold strictly for laboratory research and is not for human or veterinary use.

Related research